Sept. 16 Financial Quick Takes: Karyopharm, Mission Bay, Autolus, BenevolentAI, Edigene

Karyopharm in $150M royalty deal
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) entered into a royalty deal with HealthCare Royalty Partners under which it could receive up to $150 million tied to multiple myeloma drug Xpovio selinexor. Karyopharm will receive

Read the full 364 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE